Laivaphar SA
Laivaphar reported total assets of 679,253 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Laivaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets +14 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Laivaphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,146 € | ||||
| Equity | 378,962 € | ||||
| Cash | 47,036 € | ||||
| EBITDA | 98,005 € | ||||
| Total assets | 679,253 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 30 Sep 2023filed on 19 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Laivaphar's financial analysis
- Solvency55.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Laivaphar
Laivaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.291.139
- VAT number
- BE0459291139
- Peppol
- Registered · 0208:0459291139 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Nov 1996
- Registered office
- 3300 Tienen
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Laivaphar (SA) has been based in Tienen since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,146 € and equity of 378,962 €; its revenue is not published. Its solvency stands at 55.8%, above the median of its sector (44.2%).
Companies similar to Laivaphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Delrue Retail sale of pharmaceutical products Wielsbeke · balance sheet 679,185 €
- Hinnoya Retail sale of pharmaceutical products Tournai · balance sheet 680,362 €
- Cité-Farma Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 681,065 €
- Pharmacie DES Trieux Retail sale of pharmaceutical products Fontaine-l'Évêque · balance sheet 681,455 €
- Pharm-OZ Retail sale of pharmaceutical products Charleroi · balance sheet 681,585 €
- Staes - VAN Camp Retail sale of pharmaceutical products Grobbendonk · balance sheet 676,816 €
- Pharmaldeia Retail sale of pharmaceutical products Ghent · balance sheet 683,646 €
- Apobel Retail sale of pharmaceutical products Zottegem · balance sheet 683,671 €
Frequently asked questions about Laivaphar
What is the revenue of Laivaphar?
Laivaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Laivaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0459291139 for Laivaphar, if the company is VAT-registered. Its company number (CBE) is 0459.291.139.
Where is the registered office of Laivaphar?
According to the CBE register, the registered office of Laivaphar is in 3300 Tienen.
What is the equity of Laivaphar?
At the close of the 2025 financial year, the equity of Laivaphar amounts to 378,962 €, a solvency of 55.8% of total assets.
Who manages Laivaphar?
The register lists 2 active mandates at Laivaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Laivaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →